121-135 of 878
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Abirami Sivapiragasam
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALLNeighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Charles Turck, PharmD, BCPS, BCCCP
Lena Winestone, MD, MSHP
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Project Oncology®Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Charles Turck, PharmD, BCPS, BCCCP
Kelly McCann, MD, PhD
Gregory Vidal, MD, PhD
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstractsImproving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Ryan Quigley
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®Cosibelimab Delivers Durable Responses in Advanced CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
- advertisement
Jobelle Baldonado, MD
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®Oncogenic Drivers in Never-Smokers with NSCLC
Apar Kishor Ganti, MD, MS
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®Expanding Molecular Testing in Community NSCLC Care
Apar Kishor Ganti, MD, MS
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Brian P. McDonough, MD, FAAFP
Tara Graff, DO, MS
Surbhi Sidana, MD
Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Project Oncology®Tracking Treatment Response: ctDNA Insights in MMR-p Colon Cancer
Brian P. McDonough, MD, FAAFP
Christopher T. Chen, MD
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast CancerAddressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP
Alexis Ann LeVee, MD
- advertisement
Optimizing Care for Older Adults With FLT3-Mutated AML
On the Frontlines of AML/ALLOptimizing Care for Older Adults With FLT3-Mutated AML
Ryan Quigley
Nicholas Short, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerBiomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD
Ryan Quigley
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
